Invention Grant
- Patent Title: Steroids as agonists for FXR
-
Application No.: US15645136Application Date: 2017-07-10
-
Publication No.: US10421772B2Publication Date: 2019-09-24
- Inventor: Roberto Pellicciari
- Applicant: Intercept Pharmaceuticals, Inc.
- Applicant Address: US NY New York
- Assignee: Intercept Pharmaceuticals, Inc.
- Current Assignee: Intercept Pharmaceuticals, Inc.
- Current Assignee Address: US NY New York
- Agency: Intercept Pharmaceuticals, Inc.
- Agent Michelle Iwamoto-Fan
- Main IPC: A61K31/575
- IPC: A61K31/575 ; C07J9/00 ; C07J43/00 ; C07J41/00 ; C07C215/08 ; C07C215/10 ; C07C215/12
Abstract:
The invention relates to compounds of formula (I): wherein R is ethyl, propyl or allyl, and pharmaceutically acceptable salts, solvates or amino acid conjugates thereof. The compounds of formula (I) are useful as FXR agonists.
Public/Granted literature
- US20190300564A9 STEROIDS AS AGONISTS FOR FXR Public/Granted day:2019-10-03
Information query
